Influenza Diagnostics Market by End-user, Type, and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 170 SKU: IRTNTR44375

Influenza Diagnostics Market Forecast 2023-2027

The Global Influenza Diagnostics Market size is is forecast to increase by USD 466.18 million and estimated to grow at a CAGR of 6.95% between 2023 and 2027. The growth of the market depends on several factors, including the rising incidence of influenza, the growing demand for molecular diagnostics, and supportive government initiatives and funding. 

What will be the size of the Influenza Diagnostics Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market: Key Drivers, Trends, Challenges, and Customer Landscape

Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The rising incidence of influenza is notably driving market growth. Influenza is a common viral infection that affects a significant portion of the global population each year.  Increased demand for diagnostic tests in order to detect early and manage appropriately is caused by an increasing number of influenza cases. The market is expanding to meet growing test needs, due to the continued rise in cases of flu. These outbreaks result in a sudden surge in flu cases, creating a heightened demand for diagnostic testing to identify and track the spread of the virus. Diagnostic manufacturers respond to this seasonal demand by supplying healthcare facilities with flu diagnostic kits and assays. 

 The rising number of cases of epidemic strains in hospitals, clinics, and laboratory systems. Reliable and efficient monitoring are required by healthcare facilities to make sure that they have effective handling of larger numbers of patients during the influenza season. As a result, there is a growing demand for flu identification to aid in patient triage, treatment decisions, and infection control efforts. Such factors are expected to drive the growth of the global market during the forecast period.

Significant Market Trends

The rising adoption of rapid diagnostic products in physician office laboratories is a primary trend inmarket. The market in focus is witnessing the rising focus of manufacturers on offering low-cost and rapid tests based on immunoassays. Moreover, in order to obtain rapid test results and timely diagnosis at the clinical visit of patients, it is possible that these tests are being used widely by medical laboratories across physicians' offices. Owing to benefits from Medicare billing in the US, there has been a consistent rise in the number of physician office laboratories that have been set up.

The promotion of physician office laboratory practices is increasing owing to their support toward value-based care programs and quality payment programs through a reduction in the chances of patients undergoing hospital care. This has largely helped in promoting the adoption of physician office laboratory practices, which is contributing to the demand for epidemic testing products in such laboratories. This has mainly facilitated the adoption of laboratory practices in doctors' offices, which are contributing to the demand for epidemic testing products at these laboratories. Such factors are expected to drive the growth of the global market during the forecast period.

Major Market Challenge

The lack of laboratory infrastructure in developing regions is a major challenge faced by the market. Many developing countries face challenges in establishing and maintaining well-equipped laboratory facilities for epidemics. This limited access to diagnostic facilities hinders the timely and accurate diagnosis of influenza cases. Inadequate infrastructure, lack of trained personnel, and limited availability of diagnostic tools and reagents contribute to the challenge. The lack of laboratory infrastructure often results in limited testing capacity in developing countries. 

 It can be difficult to set up and maintain consistent laboratory infrastructure in developing countries with large geographical areas as well as remote regions. There is a lack of sufficient lab facilities in remote areas, which means that timely epidemic cure are impossible to obtain particularly in those regions where health systems are not well established. This challenge hampers disease surveillance efforts and the ability to track and respond to flu outbreaks effectively. Such factors are expected to pose a challenge to the growth of the global market during the forecast period.

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Influenza Diagnostics Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers called Alinity m Resp 4 Plex test.

The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market players, including:

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • BICO Group AB
  • Bio Rad Laboratories Inc.
  • Biocartis Group NV
  • bioMerieux SA
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Hologic Inc.
  • Princeton BioMeditech Corp.
  • QIAGEN NV
  • Response Biomedical Corp.
  • SA Scientific Ltd.

Qualitative and quantitative market growth analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Market?

The market share growth by the hospitals and diagnostic laboratories segment will be significant during the forecast period. The hospital and diagnostic laboratories segment is a significant segment of the global market. These refers to the tests and procedures used to detect and diagnose these infections. The use of flu diagnostic tests in hospital and laboratory settings is the focus of this segment. Millions of people in the world are affected by this epidemic each year, a highly contagious respiratory disease.

Get a glance at the market contribution of various segments View the PDF Sample

The hospitals and diagnostic laboratories show a gradual increase in the market share of USD 599.07 million in 2017 and continue to grow by 2021. Hospitals and diagnostic laboratories handle a substantial number of cases, requiring efficient and accurate diagnostic tools to identify the virus and determine appropriate treatment strategies. The hospital and diagnostic laboratories shall take the utmost care to provide rapid diagnosis and effective treatment for influenza. Rapid and reliable monitoring, which can help to reduce the spread of influenza in healthcare facilities, enable health professionals to take informed decisions on how patients will be treated, isolation measures, antivirals, or prevention strategies.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

North America is the major revenue contributor to the global market, owing to the growing support from the US FDA in R&D for the development of new test kits and platforms.  In North America, influenza is an important public health problem and seasonal flu outbreaks occur every year. Infrastructure is helping to ensure that different instruments are made available. The area is well served by continued technological progress in this field.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides a market research and growth analysis of the latest market trends and analysis and growth opportunities from 2017 to 2027. 

  • End-user Outlook 
    • Hospitals and diagnostic laboratories
    • Academic and research centers
    • Homecare
  • Type Outlook 
    • Point-of-care testing
    • Immunodiagnostics
    • Molecular diagnostics
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Australia 
      • Argentina
      • Rest of the World

Market Analyst Overview

The market is witnessing growth due to the demand for rapid disease diagnosis, especially given the prevalence of influenza. The market encompasses various diagnostic technologies including viral culture tests, serology tests, and rapid antigen testing like RT-PCR. These technologies cater to a wide range of healthcare settings, from large hospitals and diagnostic centers to small-scale clinics and research industries.

In response to the evolving landscape, diagnostic solutions are advancing, supported by collaborative efforts such as Collaborative Influenza Vaccine Innovation Centers (CIVICs). Specificity of diagnostic tests is crucial in minimizing false-negative and false-positive results, emphasizing the importance of a robust regulatory framework governing test kits and reagents. The market is witnessing a shift towards molecular diagnostic tests over traditional diagnostic methods, driven by the need for accuracy and efficiency. As diagnostic technologies continue to evolve, the market is poised to play a pivotal role in effective disease management and control, offering timely and accurate diagnoses to healthcare providers and patients alike.

Influenza Diagnostics Market Scope

Report Coverage

Details

Page number

170

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 6.95%

Market growth 2023-2027

USD 466.18 million

Market structure

Fragmented

YoY growth 2022-2023(%)

6.34

Regional analysis

North America, Europe, Asia, and Rest of the World (ROW)

Performing market contribution

North America at 34%

Key countries

US, Canada, Germany, France, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp.

Market dynamics

Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market in focus on the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behavior
  • Growth of the market industry across North America, Europe, Asia, and the Rest of the World (ROW)
  • Through market growth and forecasting analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report analysis of factors that will challenge the growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global Influenza Diagnostics Market 2023-2027 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
    • 4.2 End-user Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.3 Type Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
    • 6.4 Academic and research centers - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
    • 6.5 Homecare - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
      • Exhibit 43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
      • Exhibit 44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by End-user
      • Exhibit 46: Market opportunity by End-user ($ million)
      • Exhibit 47: Data Table on Market opportunity by End-user ($ million)

    7 Market Segmentation by Type

    • 7.1 Market segments
      • Exhibit 48: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
    • 7.2 Comparison by Type
      • Exhibit 50: Chart on Comparison by Type
      • Exhibit 51: Data Table on Comparison by Type
    • 7.3 Point-of-care testing - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
    • 7.4 Immunodiagnostics - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
    • 7.5 Molecular diagnostics - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
    • 7.6 Market opportunity by Type
      • Exhibit 64: Market opportunity by Type ($ million)
      • Exhibit 65: Data Table on Market opportunity by Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 China - Market size and forecast 2022-2027
      • Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 France - Market size and forecast 2022-2027
      • Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.11 Canada - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ million)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 115: Abbott Laboratories - Overview
              • Exhibit 116: Abbott Laboratories - Business segments
              • Exhibit 117: Abbott Laboratories - Key news
              • Exhibit 118: Abbott Laboratories - Key offerings
              • Exhibit 119: Abbott Laboratories - Segment focus
            • 12.4 Becton Dickinson and Co.
              • Exhibit 120: Becton Dickinson and Co. - Overview
              • Exhibit 121: Becton Dickinson and Co. - Business segments
              • Exhibit 122: Becton Dickinson and Co. - Key news
              • Exhibit 123: Becton Dickinson and Co. - Key offerings
              • Exhibit 124: Becton Dickinson and Co. - Segment focus
            • 12.5 BICO Group AB
              • Exhibit 125: BICO Group AB - Overview
              • Exhibit 126: BICO Group AB - Business segments
              • Exhibit 127: BICO Group AB - Key offerings
              • Exhibit 128: BICO Group AB - Segment focus
            • 12.6 Bio Rad Laboratories Inc.
              • Exhibit 129: Bio Rad Laboratories Inc. - Overview
              • Exhibit 130: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 131: Bio Rad Laboratories Inc. - Key news
              • Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
            • 12.7 Biocartis Group NV
              • Exhibit 134: Biocartis Group NV - Overview
              • Exhibit 135: Biocartis Group NV - Product / Service
              • Exhibit 136: Biocartis Group NV - Key offerings
            • 12.8 bioMerieux SA
              • Exhibit 137: bioMerieux SA - Overview
              • Exhibit 138: bioMerieux SA - Product / Service
              • Exhibit 139: bioMerieux SA - Key offerings
            • 12.9 Danaher Corp.
              • Exhibit 140: Danaher Corp. - Overview
              • Exhibit 141: Danaher Corp. - Business segments
              • Exhibit 142: Danaher Corp. - Key news
              • Exhibit 143: Danaher Corp. - Key offerings
              • Exhibit 144: Danaher Corp. - Segment focus
            • 12.10 DiaSorin SpA
              • Exhibit 145: DiaSorin SpA - Overview
              • Exhibit 146: DiaSorin SpA - Business segments
              • Exhibit 147: DiaSorin SpA - Key news
              • Exhibit 148: DiaSorin SpA - Key offerings
              • Exhibit 149: DiaSorin SpA - Segment focus
            • 12.11 F. Hoffmann La Roche Ltd.
              • Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.12 Hologic Inc.
              • Exhibit 155: Hologic Inc. - Overview
              • Exhibit 156: Hologic Inc. - Business segments
              • Exhibit 157: Hologic Inc. - Key news
              • Exhibit 158: Hologic Inc. - Key offerings
              • Exhibit 159: Hologic Inc. - Segment focus
            • 12.13 Princeton BioMeditech Corp.
              • Exhibit 160: Princeton BioMeditech Corp. - Overview
              • Exhibit 161: Princeton BioMeditech Corp. - Product / Service
              • Exhibit 162: Princeton BioMeditech Corp. - Key offerings
            • 12.14 Quidelortho Corp.
              • Exhibit 163: Quidelortho Corp. - Overview
              • Exhibit 164: Quidelortho Corp. - Product / Service
              • Exhibit 165: Quidelortho Corp. - Key offerings
            • 12.15 Sd Biosensor Inc.
              • Exhibit 166: Sd Biosensor Inc. - Overview
              • Exhibit 167: Sd Biosensor Inc. - Product / Service
              • Exhibit 168: Sd Biosensor Inc. - Key offerings
            • 12.16 Siemens Healthineers AG
              • Exhibit 169: Siemens Healthineers AG - Overview
              • Exhibit 170: Siemens Healthineers AG - Business segments
              • Exhibit 171: Siemens Healthineers AG - Key news
              • Exhibit 172: Siemens Healthineers AG - Key offerings
              • Exhibit 173: Siemens Healthineers AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 174: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 176: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations
              • growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
                • product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.

                  Research Framework

                  Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                  INFORMATION SOURCES

                  Primary sources

                  • Manufacturers and suppliers
                  • Channel partners
                  • Industry experts
                  • Strategic decision makers

                  Secondary sources

                  • Industry journals and periodicals
                  • Government data
                  • Financial reports of key industry players
                  • Historical data
                  • Press releases

                  DATA ANALYSIS

                  Data Synthesis

                  • Collation of data
                  • Estimation of key figures
                  • Analysis of derived insights

                  Data Validation

                  • Triangulation with data models
                  • Reference against proprietary databases
                  • Corroboration with industry experts

                  REPORT WRITING

                  Qualitative

                  • Market drivers
                  • Market challenges
                  • Market trends
                  • Five forces analysis

                  Quantitative

                  • Market size and forecast
                  • Market segmentation
                  • Geographical insights
                  • Competitive landscape

                  PURCHASE FULL REPORT OF

                  influenza diagnostics market

                  QUICK BUY

                  Key Questions Answered

                  • What are the key global market and the regional market share?
                  • What are the revenue-generating key market segments?
                  • What are the key factors driving and challenging this market’s growth?
                  • Who are the key market vendors and their growth strategies?
                  • What are the latest trends influencing the growth of this market?
                  • What are the variables influencing the market growth in the primary regions?
                  • What are the factors influencing the growth of the parent market?

                  Why should you prefer Technavio's market insights report?

                  • Off-the-shelf research reports
                  • Reports can be tailored to meet the customer's needs
                  • Trusted by more than 100 fortune 500 organizations
                  • Information about the market's key drivers, trends, and challenges
                  • Parent market analysis
                  • Every week, 50,000 people visit our subscription platform
                  • Detailed vendors report with competitive landscape
                  • Covid-19 impact and recovery analysis
                  • Data on revenue-generating market segments
                  • Details on the market shares of various regions
                  • Five-force market analysis